What does Agios Pharmaceuticals, Inc. do?
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults…
What is Agios Pharmaceuticals, Inc.'s P/E and P/B ratio?
Agios Pharmaceuticals, Inc. has a P/E ratio of -5.3 and a P/B ratio of 2.16.
What is Agios Pharmaceuticals, Inc.'s debt-to-equity ratio?
Agios Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.03.
How much does Agios Pharmaceuticals, Inc. owe compared with what it owns?
Agios Pharmaceuticals, Inc. owes $0.07 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Agios Pharmaceuticals, Inc.'s Positivity rank?
Agios Pharmaceuticals, Inc. is ranked #4,845 of 6,774 companies globally and #2,529 of 4,000 in United States on PositoAI, with a Positivity Score of 18,883.
Does Agios Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Agios Pharmaceuticals, Inc..
Where can I read the latest news about Agios Pharmaceuticals, Inc.?
Recent headlines about Agios Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Agios Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Agios Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.